Real-World Study of EGFR-TKIs Combined With Radiotherapy in Patients With Brain Metastases From Non-small Cell Lung Cancer

被引:0
|
作者
Liu, Yi [1 ]
Zhu, Yaning [1 ]
机构
[1] Shaanxi Prov peoples Hosp, Dept Oncol, Xian, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PP.06
引用
收藏
页码:S11 / S11
页数:1
相关论文
共 50 条
  • [1] Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in non-small cell lung cancer: A real-world study
    Wu, F.
    Wu, S. X.
    Hu, H. C.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [2] Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in non-small cell lung cancer: A real-world study.
    Wu, Fang
    Wu, Sixuan
    Hu, Chunhong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in EGFR-mutated non-small cell lung cancer: A real-world study
    Hu, Chunhong
    Wu, Sixuan
    Deng, Renfang
    Wu, Yuanqiang
    Pan, Yue
    Shu, Long
    Wu, Fang
    [J]. CANCER MEDICINE, 2023, 12 (01): : 266 - 273
  • [4] Real-world impact of brain metastases on healthcare utilization and costs in patients with non-small cell lung cancer treated with EGFR-TKIs in the US
    Kong, Amanda M.
    Pavilack, Melissa
    Huo, Hairong
    Shenolikar, Rahul
    Moynihan, Meghan
    Marchlewicz, Elizabeth H.
    Chebili-Larson, Christina
    Min, Stella
    Subramaniam, Deepa S.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 328 - 338
  • [5] Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases
    Yu, Xiaoqing
    Sheng, Jiamin
    Pan, Guoqiang
    Fan, Yun
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (05) : 1121 - 1128
  • [6] The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study
    Yu, Xiaoqing
    Si, Jinfei
    Wei, Jingwen
    Wang, Yanling
    Sun, Yan
    Jin, Jianan
    Zhang, Xiaoyan
    Ma, Tonghui
    Song, Zhengbo
    [J]. CANCER MEDICINE, 2023, 12 (05): : 5630 - 5638
  • [7] Clinical efficacy and safety of apatinib combined with EGFR-TKIs in advanced non-small cell lung cancer with EGFR-TKIs resistance
    Tian, Ruifen
    Guo, Yi
    Zhang, Xia
    Zhang, Xing
    Guo, Wei
    Zhu, Haibo
    Xu, Junjun
    Shen, Fangfang
    Song, Xia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer
    Zhao, Dan
    Chen, Xuejing
    Qin, Na
    Su, Dan
    Zhou, Lijuan
    Zhang, Quan
    Li, Xi
    Zhang, Xinyong
    Jin, Mulan
    Wang, Jinghui
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [9] The prognostic role of EGFR-TKIs for patients with advanced non-small cell lung cancer
    Dan Zhao
    Xuejing Chen
    Na Qin
    Dan Su
    Lijuan Zhou
    Quan Zhang
    Xi Li
    Xinyong Zhang
    Mulan Jin
    Jinghui Wang
    [J]. Scientific Reports, 7
  • [10] ANALYSIS OF THE EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER PATIENTS AFTER EGFR-TKIS TREATMENT
    Matsuo, Midori
    Nanae, Tomonaga
    Koichi, Izumikawa
    Hiroyuki, Yamaguchi
    Takaya, Ikeda
    Katsumi, Nakatomi
    Yoichi, Nakamura
    Kazuhiro, Tsukamoto
    Shigeru, Kohno
    [J]. RESPIROLOGY, 2010, 15 : 68 - 68